<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03250507</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 10655</org_study_id>
    <nct_id>NCT03250507</nct_id>
  </id_info>
  <brief_title>Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy</brief_title>
  <official_title>Mixture of Liposomal Bupivicaine and Bupivicaine Hydrogen Chloride (HCl) May Provide Faster and Longer Lasting Analgesia in Transversus Abdominis Block for Patient Having Open Abdominal Hysterectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate the effectiveness of different formulations of
      bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain
      management after open abdominal hysterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All eligible patients who consent to the study will be randomized to one of three groups.
      Group 1 will receive a TAP block with 60 mL 0.25% bupivacaine. Group 2 will receive a TAP
      block with 20 mL liposomal bupivacaine and 40 mL saline. Group 3 will receive a TAP block
      with 20 mL liposomal bupivacaine and 40 mL 0.25% bupivacaine. Patients will be assessed in
      the post-anesthesia care unit (PACU) at once each on Post-operative day 1,2, and 3.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to one of three study groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The patient, surgical team, nursing team, anesthesia team, and outcomes assessor will be blinded to the group assignment. The anesthetist performing the TAP block will not be blinded to the group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total opioid consumption during the first 72 hours postoperatively as measured in morphine equivalents (mg)</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>Total opioid consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to first opioid consumption as measured in hours until the first dose of breakthrough opioid medication given</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>time to first opioid given</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction using 3 point scale - very satisfied, satisfied, not satisfied</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>Patient satisfaction post-operatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in the hospital</measure>
    <time_frame>1 week or until patient is discharged from the hospital, whichever is longer</time_frame>
    <description>Length of stay in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>timing of ambulation</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>When the patient first ambulated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting on a two point scale - present or absent</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>Presence of nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with local anesthetic toxicity</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>Presence of local anesthetic toxicity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with hypotension &lt; 90 mmHg systolic</measure>
    <time_frame>0 - 72 hours post-operatively</time_frame>
    <description>Presence of hemodynamic instability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain scores using visual analogue scale ( 0-10)</measure>
    <time_frame>0-72 postoperative pain scores</time_frame>
    <description>Pain scores in 0-72 hours postoperative</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a TAP block with 60 mL 0.25% bupivacaine. this group will not receive Liposomal bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liposomal bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a TAP block with 20 mL liposomal bupivacaine and 40 mL saline.
this group will not receive bupivacaine. they receive only liposomal bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liposomal bupivacaine and bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a TAP block with 20 mL liposomal bupivacaine and 40 mL 0.25% bupivacaine.
this group will receive the mixture of Liposomal bupivacaine and bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>0.25% bupivacaine for TAP block</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_label>Liposomal bupivacaine and bupivacaine</arm_group_label>
    <other_name>Marcaine, Sensorcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal bupivacaine</intervention_name>
    <description>Exparel for TAP block</description>
    <arm_group_label>Liposomal bupivacaine</arm_group_label>
    <arm_group_label>Liposomal bupivacaine and bupivacaine</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline for TAP block that will be mixed with liposomal bupivacaine to bring the liposomal bupivacaine group to 60 mL total volume.</description>
    <arm_group_label>Liposomal bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective open abdominal hysterectomy with midline incision, age &gt; 18 years, American
             Society of Anesthesiologist classification score (ASA classification) 1-3.

        Exclusion Criteria:

          -  Patient with a chronic pain condition, major unexpected surgical complication,
             unexpected prolonged intubation, patient refusal, local anesthetic allergy, any
             contraindication to regional anesthesia, greater than 2 attempts by resident and
             greater than 1 attempt by staff anesthesiologist for TAP block.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Eligible patients are undergoing open abdominal hysterectomy and therefore are female.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed-Rida Alsaden, MBChB FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed-Rida Alsaden, MBChB FRCPC</last_name>
    <phone>313-283-1082</phone>
    <email>malsade1@hfhs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed-Rida Alsaden, MBChB FRCPC</last_name>
      <phone>313-283-1082</phone>
      <email>malsade1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Christina Fidkowski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nandak Choksi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rabbie Hanna, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2017</study_first_submitted>
  <study_first_submitted_qc>August 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2017</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Mohamed Rida Alsaden</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>TAP block</keyword>
  <keyword>Liposomal bupivicaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual patient data will be available to only study researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

